Physician profile
Andrew Baxter
NPI 1124346481
$10,911.96
in general payments reported to CMS, 2019-2025
32 companies · $3,095 in 2025
The $3,095 reported for 2025 was more than what 78% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,438 · 2020: $1,220 · 2021: $954 · 2022: $1,399 · 2023: $675 · 2024: $2,131 · 2025: $3,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,660 · Long Term Medical Supply Or Device Loan: $2,317 · Travel and Lodging: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,659.94 |
| Long Term Medical Supply Or Device Loan | $2,316.67 |
| Travel and Lodging | $923.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,357.32 | 2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Inari Medical, INC. | $1,553.77 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Medical LLC | $1,144.00 | 2019-2025 | Zilver Ptx, Rosen, Zilver Vena |
| Silk Road Medical, INC. | $1,123.66 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $796.86 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $754.13 | 2020-2025 | Eliquis |
| Endologix LLC | $631.30 | 2022-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System, Endocross Device |
| Philips North America LLC | $571.51 | 2019-2022 | |
| Medtronic USA, INC. | $473.84 | 2020 | |
| Boston Scientific Corporation | $428.66 | 2021-2025 | Enroute Transcarotid Neuroprotection System |
| Tactile Systems Technology INC | $133.29 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Pfizer INC. | $120.98 | 2019-2025 | |
| Medtronic, INC. | $119.03 | 2021-2024 | Ellipsys Vascular Access System |
| Medtronic Vascular, INC. | $90.18 | 2019-2020 | |
| Cardiovascular Systems INC. | $73.70 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veryan Medical Incorporated | $59.21 | 2021 | |
| Smith+Nephew, INC. | $51.65 | 2019-2022 | |
| Asahi Intecc USA, INC. | $49.85 | 2025 | Asahi Peripheral Vascular Wires |
| Penumbra, INC. | $46.58 | 2022-2025 | Penumbra System |
| Lemaitre Vascular, INC. | $45.86 | 2022-2023 | Restoreflow |
| Stryker Corporation | $45.53 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kci USA, INC. | $37.99 | 2019 | |
| Davol INC. | $37.04 | 2025 | Arista |
| Solventum Corporation | $28.27 | 2024-2025 | Promogran Prisma, Activ.A.C., Prevena |
| Abbott Laboratories | $24.77 | 2025 | Esprit |
| Teleflex LLC | $19.55 | 2021 | |
| Bard Peripheral Vascular, INC. | $18.08 | 2019 | |
| Haemonetics Corporation | $16.91 | 2023 | Teg6s Hemostasis System |
| Reprise Biomedical, INC. | $15.91 | 2023 | Miro3d, Miroderm |
| Biocompatibles, INC. | $15.64 | 2019 | |
| Cordis US Corp. | $13.70 | 2023 | Exoseal |
| Integra Lifesciences Corporation | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.